Showing results (991-1000 of 4,136) with videos related to

Sort By:
Pageof 414
Human Gene Therapy|October 8, 2026
Automated Production of Gene-Edited CAR-T Cells for People Living with HIVLea Isabell Schwarze, Niklas Nuppenau, Jan Hendrik Müller, et al.
Human Gene Therapy|October 16, 2026
Complement Activation Within Minutes Following Systemic Administration of AAV in the Presence of AAV ImmunityAnthony Caragiulo, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|October 23, 2026
Association Between Intramuscular Injection Site and Ulcer Healing in Patients with Chronic Limb-Threatening Ischemia Treated with Recombinant Human Hepatocyte Growth Factor Naked Plasmid: A Post Hoc Analysis of the HOPE CLTI-2 TrialPeng Wang, Wenzhuo Lian, Zhihua Rong, et al.
Human Gene Therapy|December 14, 2022
Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy ModelNalinda B Wasala, Yongping Yue, Bryan Hu, et al.
Human Gene Therapy|October 13, 2020
A Single Injection of an Optimized Adeno-Associated Viral Vector into Cerebrospinal Fluid Corrects Neurological Disease in a Murine Model of GM1 GangliosidosisChristian Hinderer, Brenden Nosratbakhsh, Nathan Katz, et al.
Human Gene Therapy|October 14, 2020
Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient SamplesSadia Zafar, Saru Basnet, Inga-Maria Launonen, et al.
Human Gene Therapy|March 29, 2020
Efficacy of an Oncolytic Adenovirus Driven by a Chimeric Promoter and Armed with Decorin Against Renal Cell CarcinomaWen Zhang, Chen Zhang, Weiping Tian, et al.
Human Gene Therapy|September 16, 2020
Gene Editing for the Treatment of Primary Immunodeficiency DiseasesRajeev Rai, Adrian J Thrasher, Alessia Cavazza
Human Gene Therapy|July 13, 2021
Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus VectorsAnh K Lam, Dylan Frabutt, Lei Li, et al.
Human Gene Therapy|July 9, 2021
Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway In VivoAmina Ahmad, Mawj Mandwie, Anna K Dreismann, et al.
Pageof 414